<VariationArchive VariationID="203597" VariationName="NM_000018.4(ACADVL):c.507_527del (p.Met169_Gly175del)" VariationType="Deletion" Accession="VCV000203597" Version="22" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-06-23" DateCreated="2015-07-18" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="200321" VariationID="203597">
      <GeneList>
        <Gene Symbol="ACADVL" FullName="acyl-CoA dehydrogenase very long chain" GeneID="37" HGNC_ID="HGNC:92" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7217125" stop="7225266" display_start="7217125" display_stop="7225266" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7120443" stop="7128585" display_start="7120443" display_stop="7128585" Strand="+" />
          </Location>
          <OMIM>609575</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000018.4(ACADVL):c.507_527del (p.Met169_Gly175del)</Name>
      <CanonicalSPDI>NC_000017.11:7221557:CGTGGGCATGCATGACCTTGGCGTGGGCAT:CGTGGGCAT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7221558" stop="7221578" display_start="7221558" display_stop="7221578" variantLength="21" positionVCF="7221557" referenceAlleleVCF="TCGTGGGCATGCATGACCTTGG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7124877" stop="7124897" display_start="7124877" display_stop="7124897" variantLength="21" positionVCF="7124876" referenceAlleleVCF="TCGTGGGCATGCATGACCTTGG" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_000018.4(ACADVL):c.507_527del</Name>
        <Name>p.Met169_Gly175del</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7124886_7124906del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7124886_7124906del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7221567_7221587del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7221567_7221587del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007975.1" sequenceAccession="NG_007975" sequenceVersion="1" change="g.6734_6754del">
            <Expression>NG_007975.1:g.6734_6754del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008391.2" sequenceAccession="NG_008391" sequenceVersion="2" change="g.3473_3493del">
            <Expression>NG_008391.2:g.3473_3493del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000018.4" sequenceAccession="NM_000018" sequenceVersion="4" change="c.507_527del" MANESelect="true">
            <Expression>NM_000018.4:c.507_527del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000009.1" sequenceAccession="NP_000009" sequenceVersion="1" change="p.Met169_Gly175del">
            <Expression>NP_000009.1:p.Met169_Gly175del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001033859.3" sequenceAccession="NM_001033859" sequenceVersion="3" change="c.441_461del">
            <Expression>NM_001033859.3:c.441_461del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001029031.1" sequenceAccession="NP_001029031" sequenceVersion="1" change="p.Met147_Gly153del">
            <Expression>NP_001029031.1:p.Met147_Gly153del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270447.2" sequenceAccession="NM_001270447" sequenceVersion="2" change="c.576_596del">
            <Expression>NM_001270447.2:c.576_596del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257376.1" sequenceAccession="NP_001257376" sequenceVersion="1" change="p.Met192_Gly198del">
            <Expression>NP_001257376.1:p.Met192_Gly198del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270448.2" sequenceAccession="NM_001270448" sequenceVersion="2" change="c.279_299del">
            <Expression>NM_001270448.2:c.279_299del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001257377.1" sequenceAccession="NP_001257377" sequenceVersion="1" change="p.Met93_Gly99del">
            <Expression>NP_001257377.1:p.Met93_Gly99del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA312294" DB="ClinGen" />
        <XRef Type="rs" ID="796051920" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000018.4(ACADVL):c.507_527del (p.Met169_Gly175del) AND not provided" Accession="RCV000185744" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2014-09-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000018.4(ACADVL):c.507_527del (p.Met169_Gly175del) AND Very long chain acyl-CoA dehydrogenase deficiency" Accession="RCV001200826" Version="22">
        <ClassifiedConditionList TraitSetID="417">
          <ClassifiedCondition DB="MedGen" ID="C3887523">Very long chain acyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2024-02-27" SubmissionCount="6">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-27" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2015-07-18" MostRecentSubmission="2024-06-17">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Uncertain significance</Description>
        <Citation Type="general">
          <ID Source="PubMed">17999356</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18670371</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23430950</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26881790</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31031081</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/187501cc-93fb-4525-8ff0-1e7e358dccad</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://www.semantisholar.org/paper/Prevalene-and-Geneti-Variability-of-Inborn-Errors-Al-Jishi-Alsahlawi/35fe29d36bd12f0fbe1020298d43d77eea5310f7</URL>
        </Citation>
        <DescriptionHistory Dated="2024-03-29">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-07-11">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="417" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="27" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VLCAD deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Very long chain acyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="VLCAD+deficiency/7410" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008723" DB="MONDO" />
                <XRef ID="237997005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">VLCADD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VLCAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ACADVLD</ElementValue>
                <XRef Type="MIM" ID="201475" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Deficiency of very long-chain acyl-coenzyme A dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial beta-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons, is associated with three phenotypes. The severe early-onset cardiac and multiorgan failure form typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia. The hepatic or hypoketotic hypoglycemic form typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly, but without cardiomyopathy. The later-onset episodic myopathic form presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms.</Attribute>
                <XRef ID="NBK6816" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5508" />
                <XRef ID="5508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301763</ID>
                <ID Source="BookShelf">NBK6816</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2021">
                <URL>https://managementguidelines.net/guidelines.php/130/VLCAD%20Nutrition%20Guidelines/Version%201.1</URL>
                <CitationText>VLCAD Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C14.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C14:1 +/- other long-chain acylcarnitines, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI, 2022">
                <URL>https://managementguidelines.net/guidelines.php/146/VLCAD%20Nutrition%20Guidelines/Version%201.4</URL>
                <CitationText>GMDI (SERN), VLCAD Nutrition Management Guidelines, v. 1.4, 2022</CitationText>
              </Citation>
              <XRef ID="26793" DB="Orphanet" />
              <XRef ID="C3887523" DB="MedGen" />
              <XRef ID="MONDO:0008723" DB="MONDO" />
              <XRef Type="MIM" ID="201475" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="441823" SubmissionDate="2015-07-14" DateLastUpdated="2015-07-18" DateCreated="2015-07-18">
        <ClinVarSubmissionID localKey="1482" />
        <ClinVarAccession Accession="SCV000238673" DateUpdated="2015-07-18" DateCreated="2015-07-18" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-09-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.507_527delGCATGACCTTGGCGTGGGCAT mutation causes an in-frame deletion of 7 amino acids starting at Methionine 169 and ending with Glycine 175, denoted Met169_Gly175del. This deletion occurs within a a region that is conserved in mammals and includes residues that are conserved across species. Missense mutations in this region (V174A, V174M) have been reported in association with very long chain acyl-CoA dehydrogenase (VLCAD) deficiency, supporting the functional importance of this region of the protein. Although this mutation has not been previously reported to our knowledge, we interpret c.507_527delGCATGACCTTGGCGTGGGCAT to be a pathogenic mutation. The variant is found in ACADVL panel(s).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.M169_G175del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.2:c.507_527delGCATGACCTTGGCGTGGGCAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="8983592" SubmissionDate="2024-03-27" DateLastUpdated="2024-03-30" DateCreated="2024-03-30">
        <ClinVarSubmissionID localKey="187501cc-93fb-4525-8ff0-1e7e358dccad" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004805218" DateUpdated="2024-03-30" DateCreated="2024-03-30" Type="SCV" Version="1" SubmitterName="ClinGen ACADVL Variant Curation Expert Panel, ClinGen" OrgID="508473" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-27">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Uncertain Significance</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/187501cc-93fb-4525-8ff0-1e7e358dccad</URL>
          </Citation>
          <Comment>The NM_000018.4 c.507_527del (p.Met169_Gly175del) variant in ACADVL is an in-frame deletion (removes amino acids Met169_Gly175) in exon7/20 that is not predicted to impact splicing (SpliceAI: 0.0200). The highest population minor allele frequency in gnomAD v4.0.0 is 0.0001 in Middle Eastern population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (&lt;0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). The c.507_527del variant is predicted to cause a change in the length of the protein (p. Met169_Gly175del) due to an in-frame deletion of seven amino acids in a non-repeat region (PM4). This variant is reported in the literature in two individuals affected with very long-chain acyl-CoA dehydrogenase deficiency in a heterozygous fashion, who displayed elevated C14:1 carnitine level (0.8 and 1.14 Âµmol/L, respectively) during newborn screening and reduced VLCAD enzyme levels in the latter one of them, which is highly specific for VLCAD deficiency (PP4_Moderate, PMID: 31031081). Due to limited evidence, this variant is classified as a variant of uncertain significance for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PM2_Supporting, PM4, PP4_Moderate (ACADVL VCEP specifications version 1; approved November 9, 2021).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">clingen acadvl acmg specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/iz6xgwit/clingen_acadvl_acmg_specifications_v1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000018.4(ACADVL):c.507_527del</Name>
            <Name>p.Met169_Gly175del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.7221567_7221587del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0008723" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14342008</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9816500" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000018.4:c.507_527del|OMIM:201475" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005058292" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.4:c.507_527del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201475" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2704384" SubmissionDate="2020-07-13" DateLastUpdated="2020-07-16" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="NM_000018.3:c.507_527del21|OMIM:201475" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001365027" DateUpdated="2020-07-16" DateCreated="2020-07-16" Type="SCV" Version="2" SubmitterName="Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine" OrgID="506302" OrganizationCategory="laboratory" OrgAbbreviation="WongLab-BCM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The NM_000018.3:c.507_527del21 (NP_000009.1:p.Met169_Gly175del) [GRCH38: NC_000017.11:g.7221567_7221587del] variant in ACADVL gene is interpretated to be Uncertain Significance based on ACMG guidelines (PMID: 25741868). This variant has been reported. This variant dose not meet any evidence codes reported in the ACMG guidelines.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.3:c.507_527del21</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201475" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7761254</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2902166" SubmissionDate="2020-12-11" DateLastUpdated="2021-01-26" DateCreated="2021-01-26">
        <ClinVarSubmissionID localKey="2463476|OMIM:201475" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001473503" DateUpdated="2021-01-26" DateCreated="2021-01-26" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Comment>The ACADVL c.507_527del21; p.Met169_Gly175del variant (rs1387074573) is reported in the literature in the heterozygous state in individuals affected with very long-chain acyl-CoA dehydrogenase deficiency (Rovelli 2019). This variant is reported in ClinVar (Variation ID: 203597), and is only observed on one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant deletes seven amino acid residues leaving the rest of the protein in-frame. Without functional studies, the effect on the protein is unknown. Due to limited information, the clinical significance of the p.Met169_Gly175del variant is uncertain at this time. References: Rovelli V et al. Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2019 May;127(1):64-73.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/w2yp3qyt/arup_molecular_germline_variant_investigation_process.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.7124886_7124906delGCATGACCTTGGCGTGGGCAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201475" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2020 ARUP</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3414181" SubmissionDate="2021-06-10" DateLastUpdated="2021-06-19" DateCreated="2021-06-19">
        <ClinVarSubmissionID localKey="17:7124876" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001736884" DateUpdated="2021-06-19" DateCreated="2021-06-19" Type="SCV" Version="1" SubmitterName="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" OrgID="505530" OrganizationCategory="laboratory" OrgAbbreviation="HA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>ACMG codes:PM1, PM2, PM4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">17:7124876:T:LSU00058</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001631" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001680" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000018.4:c.507_527del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="201475" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>CSER-SouthSeq</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9828428</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2923684" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-03-07">
        <ClinVarSubmissionID localKey="9402764|MedGen:C3887523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001484054" DateUpdated="2024-02-20" DateCreated="2021-03-07" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17999356</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18670371</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23430950</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26881790</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31031081</ID>
          </Citation>
          <Citation>
            <URL>https://www.semantisholar.org/paper/Prevalene-and-Geneti-Variability-of-Inborn-Errors-Al-Jishi-Alsahlawi/35fe29d36bd12f0fbe1020298d43d77eea5310f7</URL>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Val174 amino acid residue in ACADVL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17999356, 18670371, 23430950, 26881790). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has been observed in individual(s) with VLCAD deficiency (PMID: 31031081, Invitae, https://www.semanticscholar.org/paper/Prevalence-and-Genetic-Variability-of-Inborn-Errors-Al-Jishi-Alsahlawi/35fe29d36bd12f0fbe1020298d43d77eea5310f7). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 203597). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant, c.507_527del, results in the deletion of 7 amino acid(s) of the ACADVL protein (p.Met169_Gly175del), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.7124877_7124897del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887523" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3414181" TraitType="Disease" MappingType="XRef" MappingValue="201475" MappingRef="OMIM">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2902166" TraitType="Disease" MappingType="XRef" MappingValue="201475" MappingRef="OMIM">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2923684" TraitType="Disease" MappingType="XRef" MappingValue="C3887523" MappingRef="MedGen">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2704384" TraitType="Disease" MappingType="XRef" MappingValue="201475" MappingRef="OMIM">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9816500" TraitType="Disease" MappingType="XRef" MappingValue="201475" MappingRef="OMIM">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="441823" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3414181" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001680" MappingRef="HP">
        <MedGen CUI="C0003492" Name="Coarctation of aorta" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3414181" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001631" MappingRef="HP">
        <MedGen CUI="C0018817" Name="Atrial septal defect" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8983592" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0008723" MappingRef="MONDO">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

